Prognostic factors in locally advanced oesophageal squamous cell carcinoma: a clinical and radiomic analysis of neoadjuvant immunochemotherapy before surgery
For patients with LAESCC treated with NIC followed by surgery, the combined model effectively evaluated the efficacy of NIC and predicted PFS and OS. Additionally, different independent predictors were associated with PFS and OS, providing clues for future studies.
Authors
- Qingqing Xu (ORCID: https://orcid.org/0000-0002-7703-5872)
- Genji Bai (ORCID: https://orcid.org/0000-0002-6891-9721)
- Lili Guo (ORCID: https://orcid.org/0000-0002-4034-6968)
- Mingzi Gao (ORCID: https://orcid.org/0009-0006-3777-9320)
- Lili Zhang (ORCID: https://orcid.org/0000-0002-9341-5832)
- Zhenzhong Zhang (ORCID: https://orcid.org/0000-0002-1606-6835)
- Shuangqing Chen (ORCID: https://orcid.org/0000-0002-1504-4773)
- Yan Zhu (ORCID: https://orcid.org/0000-0002-6932-7971)
- Aichao Ruan
Institutions
- Xuzhou Medical College (CN)
- Huaian First People’s Hospital (CN)
- Suzhou Municipal Hospital (CN)
- Second People’s Hospital of Huai’an (CN)
- Nanjing Medical University (CN)
- University of California, Davis (US)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-03-13
- DOI
- https://doi.org/10.3389/fonc.2025.1508477
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00